Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235599 · ClinicalTrials.gov registry record
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
A clinical trial, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 10
- Enrollment target
NCT00235599: Completed study, sponsored by University of Massachusetts, Worcester.
NCT00235599 is a clinical trial that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00235599 has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This project is designed to answer the question: Is there an acute IGFBP-3 response in normal children? Our specific hypothesis states that under the influence of growth hormone secretagogues, intact IGFBP-3 molecule will undergo proteolysis and liberate IGFBP-3 fragments, along with other components of the ternary complex. This proteolysis will result in measurable rise in IGFBP-3, which will indicate the subject's growth hormone status. Short children with growth hormone deficiency will not show an IGFBP-3 response.
Interventions
- PROCEDURE IGFBP-3 Stimulation Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-10 |
What the finished NCT00235599 record still lists
NCT00235599 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which IGFBP-3 Stimulation Test is the first listed.
NCT00235599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00235599 about?
NCT00235599 is a clinical study titled "The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.". This project is designed to answer the question: Is there an acute IGFBP-3 response in normal children? Our specific hypothesis states that under the influence of growth hormone secretagogues, intact IGFBP-3 molecule will undergo proteolysis and liberate IGFBP-3 fragments, along with other componen...
What is the current status of trial NCT00235599?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2005-09. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00235599?
The interventions under investigation include: IGFBP-3 Stimulation Test (PROCEDURE).
Who is sponsoring clinical trial NCT00235599?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia